Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016 - Erlotinib - Document - PDFSEARCH.IO

First Page	Meta Content
	Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016 Add to Reading List Document Date: 2016-07-22 09:17:34 Open Document File Size: 281,50 KB Share Result on Facebook

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016Add to Reading List